Estropipate

   
Google
 
Web NewDrugInformation.com

Estropipate


Drug - Estropipate
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Estropipate
Multiple ingredients are in alphabetical order.

Strength - 3MG
The potency of the active ingredient(s), Estropipate. May repeat for multiple part products.

Applicant - DURAMED PHARMS BARR
The firm name holding legal responsibility for Estropipate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040296
The FDA assigned number to Estropipate. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Estropipate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Nov 1, 1999
The date Estropipate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Estropipate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Estropipate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Estropipate.

Estropipate